0.05Open0.15Pre Close40 Volume218 Open Interest84.00Strike Price233.00Turnover51.95%IV10.02%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier4DDays to Expiry0.07Extrinsic Value100Contract SizeAmericanOptions Type0.0425Delta0.0220Gamma1091.57Leverage Ratio-0.0407Theta0.0003Rho46.45Eff Leverage0.0072Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet